Ohmura et al. experimentally proved that the effect of cardiac hypertrophy agonist angiotensin II in the rat increases the LOXL1 mRNA by almost two-fold promoting enhanced myocardial stiffness (Ohmura et al., 2012). The gene discussed is AGT; the disease is cardiac hypertrophy.